| Vioxx rofecoxib - No surprise as FDA turns down Merck & |
| Wednesday, May 9, 2007 |
No as FDA turns to the bottom destempsof Merck and vioxx rofecoxib Arcoxia - of Pharma of Co (the surprisedesubscription)
No while the FDA turns towards thebasMerck and vioxx rofecoxib times of ArcoxiaPharma of Co (subscription), UK - avr. 30, FDA 2007The is clearly concern equ' arcoxiacould pose some of same the risquescardiovasculaires as thepain-soulageur withdrawn Vioxx (rofecoxib)de the company and vioxx rofecoxib ...
Source:news.google.com
Risk ofinfarction dumyocarde joined selective COX-2... -HeartZine
Risk of myocardial infarction related toCOX-2s lectif... HeartZine, UK - avr. 26, 2007We foundlecelecoxib, rofecoxib, etoricoxib, valdecoxib and vioxx rofecoxib the lumiracoxibont t associated at the higher risks SEMI compared againstleplacebo....
Source:news.google.com
Panelagainst the successeurde Vioxx - Kansas City Star
Panelagainst dessuccessorKansas of Vioxx than the Tiennent city the firstrole, mo -avr. 13, 2007Graham were principal a critic ofVioxx, droguerelative also known under the name of rofecoxib. oeWepourrait to have a rejouer of what we had with the rofecoxib, Graham known as...
Source: the pain of drugdenews.google.com
New for the panel ofFDAde Merck advises against the approval of... - pain of drugdeChicago Tribune
New for Merck panel that ofFDAconseille against the approval... of Chicago Tribune, il - avr. 13, 2007Graham were principal a critic deVioxx,also known under the name of rofecoxib. "what you parlezest apotential disaster of public health," Graham known as... del'
Source: the scientistdenews.google.com
FDA breath proposedladrogue pain - the scientist of WashingtonPost
FDAwhich the breaths proposed the post deDrugWashington pain, DC - avr. 12, 2007Graham has t un principal critic ofVioxx, also known under the name derofecoxib. Gain the inspiration ofthe thin readers of club of platqui lost the weight... and vioxx rofecoxib kept it inaddition to... del'
Source: news.google.com
|
| posted by @ Wednesday, May 9, 2007 |
|
|
|